本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Agios Pharmaceuticals, Inc.

29.10
-0.5200-1.76%
盤後29.100.00000.00%16:32 EDT
成交量:47.34萬
成交額:1,380.31萬
市值:16.85億
市盈率:2.50
高:29.68
開:29.68
低:28.94
收:29.62
資料載入中...
2025/04/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/05

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/13

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/13

重要事件披露

Form 8-K - Current report
2025/02/13

重要事件披露

Form 8-K - Current report
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/06

重要事件披露

Form 8-K - Current report
2025/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/08

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/31

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/31

重要事件披露

Form 8-K - Current report